Quest Flow (543982)
CyclicalFairStock Score: 1/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,158.6 |
| Market Cap | ₹1,177.15 Cr |
| P/E Ratio | 28.95 |
| ROCE | 12.82% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -16.88% |
| Debt/Equity | — |
| Sales Growth | -11.48% |
| 52-Week Range | ₹116.2 — ₹1,158.6 |
| Sector | Industrial Products |
Strengths
- ROCE of 12.82% shows decent capital efficiency, if it can be sustained.
- Latest quarter is still profitable, with net profit of ₹1 Cr on sales of ₹26 Cr.
- The company is generating positive earnings overall, as reflected in a P/E of 28.95 on trailing earnings.
- Being listed on NSE/BSE with a ₹1,177 Cr market cap gives it institutional accessibility.
Concerns
- Sales growth of -11.48% and profit growth of -16.88% show a clear contraction.
- Piotroski F-Score of 3/9 indicates weak fundamental health.
- Zero dividend yield provides no income support in a declining business.
- Latest quarter net margin is only ~3.8%, and the stock trades at the top of its 52-week range after a massive run-up.
AI Analysis
Let me start with what I don't know: book value, debt/equity, promoter holding—all missing. Mr. Graham said to invest in facts, not hopes. What I see is a ₹1,177 Cr company priced at 28.95 times earnings, yet sales shrank 11.48% and profits fell 16.88%. That is the opposite of a compounding machine. The latest quarter earned just ₹1 Cr on ₹26 Cr of sales—a 3.8% margin. If that is the new run-rate, the stock is dangerously expensive. The Piotroski F-score of 3/9 confirms weak financial health; only three of nine fundamental criteria are met. ROCE of 12.82% is not terrible, but with declining revenue it may erode quickly. There is no dividend to compensate me while I wait, and the share has gone from ₹116.20 to ₹1,158.60 within the 52-week range. That is a roughly 900% move, and I don't buy after ten-baggers unless the underlying earnings have grown equally; these have not. The FairStock score gives it 1/100—risky. I cannot build a margin of safety with negative sales growth, falling profits, a low F-score, and unavailable balance-sheet data. As Buffett said, it's far better to pay a fair price for a wonderful business than a wonderful price for a risky one. This is an industrial cyclical at the wrong moment in the cycle, being bid up on hope rather than performance. I would keep it in the too-hard pile and wait for evidence of stabilisation, reasonable leverage, and a lower price that provides real protection.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer